RegeneRx Biopharmaceuticals Inc RGRX:OTCQB

RT Quote | Exchange | USD
Last | 03/03/21 EST
0.65quote price arrow down-0.03 (-4.4118%)
Volume
109,177
52 week range
0.15 - 0.82

...

Loading . . .

KEY STATS

  • Open0.70
  • Day High0.70
  • Day Low0.615
  • Prev Close0.65
  • 52 Week High0.82
  • 52 Week High Date02/24/21
  • 52 Week Low0.15
  • 52 Week Low Date03/20/20
  • Market Cap86.74M
  • Shares Out133.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • 1 Year % Change162.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-57.37
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.304M
  • ROE (MRQ)-
  • Revenue (MRQ)80,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-1,960.57%
  • Debt To Equity (MRQ)-29.16%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest RegeneRx Biopharmaceuticals Inc News

There is no recent news for this security.

Latest RGRX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
RegeneRx Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of a therapeutic peptide, Thymosin beta 4 (Tb4), for tissue and organ protection, repair and regeneration. The Company's segment is the development and marketing of product candidates based on Tb4, an amino acid peptide. The Company has formulated Tb4 into three product candidates in clinical development: RGN-259, RGN-352 and RGN-137. Tb4 is a synthetic copy of a...
Allan Goldstein Ph.D.
Chairman
J. Finkelstein
President
Address
15245 Shady Grove Rd Ste 470
Rockville, MD
20850-6243
United States